Adimmune Corp (國光生技) on Thursday signed a memorandum of understanding (MOU) with Indonesia-based industrial-estate developer PT Berkah Kawasan Manyar Sejahtera (BKMS) as it eyes a new factory in Indonesia.
BKMS, a subsidiary of AKR Corporindo Tbk PT, helps foreign companies invest in Java Integrated Industrial Ports and Estate, which has been designated a special economic zone, Adimmune said.
“We will perform due diligence to determine whether to invest in the zone, and so far there is no specific timeline,” Adimmune spokesman Pan Fei (潘飛) told the Taipei Times by telephone yesterday.
“The zone is a strong candidate for overseas expansion, due to its infrastructure and advantageous policies, in addition to the large consumer base in Indonesia,” Pan said.
The Indonesian government welcomes investment from foreign biotech and pharmaceutical firms, as local production is expected to alleviate pressure on it to import drugs and vaccines, Pan said.
If Adimmune proceeds, it would produce its own influenza vaccines for the Indonesian market and others in Southeast Asia, he said, adding that the firm has halal certification for its flu shots.
It would focus on contract development and manufacturing to help clients develop their own vaccines, Pan said.
Adimmune chairman Steve Chan (詹啟賢) said at a signing ceremony on Thursday that the firm was planning clinical trials in Indonesia for its COVID-19 vaccine candidate.
Adimmune has conducted phase 1 trials in Taiwan and is considering phase 2 human trials in Indonesia, Pan said, adding that talks are ongoing with Indonesian regulators.
“We will not rush to complete the trials to obtain emergency use authorization from Indonesian regulators. Instead, the aim is for a normal approval procedure, as we believe that demand for COVID-19 vaccines will be long-term,” Pan said.
Adimmune’s cumulative sales fell 77 percent annually to NT$94 million (US$3.35 million) for the first six months.
AI BOOST: Although Taiwan’s reliance on Chinese rare earth elements is limited, it could face indirect impacts from supply issues and price volatility, an economist said DBS Bank Ltd (星展銀行) has sharply raised its forecast for Taiwan’s economic growth this year to 5.6 percent, citing stronger-than-expected exports and investment linked to artificial intelligence (AI), as it said that the current momentum could peak soon. The acceleration of the global AI race has fueled a surge in Taiwan’s AI-related capital spending and exports of information and communications technology (ICT) products, which have been key drivers of growth this year. “We have revised our GDP forecast for Taiwan upward to 5.6 percent from 4 percent, an upgrade that mainly reflects stronger-than-expected AI-related exports and investment in the third
Mercuries Life Insurance Co (三商美邦人壽) shares surged to a seven-month high this week after local media reported that E.Sun Financial Holding Co (玉山金控) had outbid CTBC Financial Holding Co (中信金控) in the financially strained insurer’s ongoing sale process. Shares of the mid-sized life insurer climbed 5.8 percent this week to NT$6.72, extending a nearly 18 percent rally over the past month, as investors bet on the likelihood of an impending takeover. The final round of bidding closed on Thursday, marking a critical step in the 32-year-old insurer’s search for a buyer after years of struggling to meet capital adequacy requirements. Local media reports
TECHNOLOGICAL RIVALRY: The artificial intelligence chip competition among multiple players would likely intensify over the next two years, a Quanta official said Quanta Computer Inc (廣達), which makes servers and laptops on a contract basis, yesterday said its shipments of artificial intelligence (AI) servers powered by Nvidia Corp’s GB300 chips have increased steadily since last month, should surpass those of the GB200 models this quarter. The production of GB300 servers has gone much more smoothly than that of the GB200, with shipments projected to increase sharply next month, Quanta executive vice president Mike Yang (楊麒令) said on the sidelines of a technology forum in Taipei. While orders for GB200 servers gradually decrease, the production transition between the two server models has been
ASE Technology Holding Co (日月光投控), the world’s largest integrated circuit (IC) packaging and testing supplier, yesterday announced a strategic collaboration with Analog Devices Inc (ADI), coupled with the signing of a binding memorandum of understanding. Under the agreement, ASE intends to purchase 100 percent shares of Analog Devices Sdn Bhd and acquire its manufacturing facility in Penang, Malaysia, a press release showed. The ADI Penang facility is located in the prime industrial hub of Bayan Lepas, with an area of over 680,000 square feet, it said. In addition, the two sides intend to enter into a long-term supply agreement for ASE to